An Alphatec VP Sold Company Shares Worth $1.4 Million. Should Investors Avoid the Stock?

Company Overview - Alphatec Holdings specializes in advanced technologies for the surgical treatment of spinal disorders, offering a portfolio that includes neural monitoring systems, fixation devices, inter-body implants, and biologics for spinal reconstruction and repair [7][8] - The company generates revenue through the sale of proprietary medical devices and biologics, targeting orthopedic and neurosurgeons, with hospitals and surgical centers as primary customers [7][8] Financial Performance - For the year 2025, Alphatec reported revenue of $764.2 million, an increase from $611.6 million in the previous year, and forecasts ongoing growth with an estimated revenue of $890 million for 2026 [11] - The company is currently not profitable, posting a net loss of $143.4 million in 2025, which is an improvement from a $162.1 million loss in 2024 [11] - As of March 9, 2026, the company's market capitalization stands at $1.88 billion, with a price of $12.87 per share, reflecting a 30.75% increase over the past year [4] Recent Transactions - Craig E. Hunsaker, Executive Vice President of People & Culture at Alphatec, sold 116,367 shares for approximately $1.44 million, which is larger than his recent-period median sale of 80,438 shares [2][6] - Post-transaction, Hunsaker retains 1,725,609 shares valued at approximately $22.21 million, indicating substantial ongoing ownership [2][6] - A portion of the shares sold (33,602 shares) was executed under a Rule 10b5-1 plan for tax obligations related to vesting restricted stock units, aligning with Hunsaker's established pattern of periodic share sales [6] Market Context - The recent share price decline of Alphatec, which has fallen from a 52-week high of $23.29 in January, may be influenced by insider selling, including Hunsaker's transaction [10] - Despite the stock price drop, the company's price-to-sales ratio of two is currently lower than it has been in months, suggesting a potential buying opportunity for investors [11]